<?xml version="1.0" encoding="UTF-8"?>
<p>Principle behind use: due to the anti-inflammatory action of baricitinib, it was independently hypothesized using artificial intelligence (AI)-algorithms to be useful for the treatment of COVID-19 infection via proposed anti-cytokine effects and as an inhibitor of host cell viral propagation. As mentioned previously, CRS has been linked to increased morbidity and mortality in COVID-19 patients. Baricitinib has been found to inhibit IL-6-induced MCP1 production from human peripheral blood mononuclear cells [
 <xref rid="REF41" ref-type="bibr">41</xref>].
</p>
